首页 | 本学科首页   官方微博 | 高级检索  
检索        

广东省新会区吸毒人群HIV和梅毒感染状况调查分析
引用本文:林金丽.广东省新会区吸毒人群HIV和梅毒感染状况调查分析[J].疾病监测,2005,20(6):299-301.
作者姓名:林金丽
作者单位:广东省江门市新会区疾病预防控制中心,广东,新会,529100
摘    要:目的了解新会区吸毒人群HIV和梅毒(TP)感染情况,为制定预防控制措施提供科学依据。方法对新会区2004年部分在押吸毒人员进行HIV和梅毒血清学检测。结果516名吸毒者血液标本中,抗-HIV的阳性率为6.4%(33/516),梅毒抗体阳性率为9.3%(48/516)。在检出的33例HIV感染者中HIV/TP双重感染率为1.2%(6/516)。女性吸毒者TP的感染率为27.1%(19/70),男性吸毒者TP的感染率为6.5%(29/446)。结论应加大对吸毒人群的监测和防病知识宣传力度,采取干预措施,降低HIV等疾病在高危人群中扩散和传播的危险性。

关 键 词:获得性免疫缺陷综合征  梅毒
文章编号:1003-9961(2005)06-0299-02
收稿时间:2005-03-08
修稿时间:2005年3月8日

Investigation on HIV and syphilis infection among drug-abusing population in Xinhui district
LIN Jin-li.Investigation on HIV and syphilis infection among drug-abusing population in Xinhui district[J].Disease Surveillance,2005,20(6):299-301.
Authors:LIN Jin-li
Institution:1.Xinhui District Center for Disease Control and Prevention of Jiangmen City;Xinhui 529100 China;
Abstract:Objective The present investigation was conducted to know HIV and syphilis infection among drug-abusing population in Xinhui district and furnish a scientific basis for formulating measures for its prevention and control. Methods Serological detection of HIV and syphilis was performed for some drug abusers in custody in 2004 in Xinhui district. Results Studies of blood samples from 516 drug abusers showed that the positive rates of anti-HIV and syphilis antibody was 6.4%(33/516) and 9.3%(48/516) respectively. Of the 33 HIV infection cases detected, the rate of HIV/TP dual infection was 1.2% (6/516). The infection rate of TP was 27.1%(19/70) in female drug abusers and 6.5%(29/446) in male drug abusers. Conclusion Surveillance should be enforced and promotion of knowledge of prevention is to be strengthened among drug-abusing population. Every intervention possible should be taken to reduce the risk of spread of HIV among high-risk population.
Keywords:Acquired immune deficiency syndrome  Syphilis
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《疾病监测》浏览原始摘要信息
点击此处可从《疾病监测》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号